Literature DB >> 9362372

Bile acid-independent bile flow is differently regulated by glucagon and secretin in humans after orthotopic liver transplantation.

R Lenzen1, J Elster, C Behrend, K E Hampel, W O Bechstein, P Neuhaus.   

Abstract

The present study characterizes recovery of bile secretion after orthotopic liver transplantation (OLT) in humans with special regard to hormonal regulation of bile acid-independent bile flow by glucagon and secretin. Sixty-seven patients with an uncomplicated postoperative course were studied during the first 3 weeks after OLT to determine normalization of bile flow. A group of 7 and 10 patients, respectively, underwent a biliary stimulation test by either glucagon at days 7, 14, and 21 after OLT or by secretin at days 2, 10, and 21 after OLT. Secretin tests were similarly performed in patients with acute severe rejection during the first 10 days after OLT, while glucagon tests were performed in patients with acute allograft rejection occurring 2 weeks after OLT. Furthermore, hormone effects were studied in nontransplanted patients after cholecystectomy with indwelling biliary T tube. After OLT, bile secretory function recovered and stabilized within 14 days after surgery by reconstitution of both bile acid-dependent and -independent bile flow. Two weeks after OLT, bile secretion was comparable with nontransplanted patients after cholecystectomy. Glucagon and secretin stimulated bile acid-independent bile flow in transplanted and nontransplanted patients significantly, yet secretin choleresis, unlike glucagon choleresis, had already occurred during the first days after OLT and was unaffected by acute allograft rejection. These results allow the speculation that, in humans, glucagon and secretin exert their choleretic activity by different mechanisms and/or at different anatomical sites in the liver. Assuming that secretin acts at the bile duct cells, its secretory capacity was not altered by the transplantation procedure and during moderate or severe rejection episodes, as opposed to glucagon choleresis, which most likely originates in the hepatocytes and requires an entirely reconstituted canalicular transport system after OLT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362372     DOI: 10.1002/hep.510260527

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Mechanosensor transient receptor potential vanilloid member 4 (TRPV4) regulates mouse cholangiocyte secretion and bile formation.

Authors:  Qin Li; Charles Kresge; Kristy Boggs; Julie Scott; Andrew Feranchak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-25       Impact factor: 4.052

Review 2.  Functional anatomy of normal bile ducts.

Authors:  Mario Strazzabosco; Luca Fabris
Journal:  Anat Rec (Hoboken)       Date:  2008-06       Impact factor: 2.064

3.  Fluid flow induces mechanosensitive ATP release, calcium signalling and Cl- transport in biliary epithelial cells through a PKCzeta-dependent pathway.

Authors:  Kangmee Woo; Amal K Dutta; Vishal Patel; Charles Kresge; Andrew P Feranchak
Journal:  J Physiol       Date:  2008-04-03       Impact factor: 5.182

4.  Mechanosensitive Cl- secretion in biliary epithelium mediated through TMEM16A.

Authors:  Amal K Dutta; Kangmee Woo; Al-karim Khimji; Charles Kresge; Andrew P Feranchak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-25       Impact factor: 4.052

Review 5.  Cholangiocyte anion exchange and biliary bicarbonate excretion.

Authors:  Jesús-M Banales; Jesus Prieto; Juan-F Medina
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

6.  Organomatics and organometrics: Novel platforms for long-term whole-organ culture.

Authors:  Bote G Bruinsma; Martin L Yarmush; Korkut Uygun
Journal:  Technology (Singap World Sci)       Date:  2014-03

7.  Cholestasis-induced adaptive remodeling of interlobular bile ducts.

Authors:  Nachiket Vartak; Amruta Damle-Vartak; Beate Richter; Olaf Dirsch; Uta Dahmen; Seddik Hammad; Jan G Hengstler
Journal:  Hepatology       Date:  2016-01-14       Impact factor: 17.425

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.